- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04257630
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
Influence of Coping Strategies on Short and Long-term Outcomes of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD)
Study Overview
Status
Detailed Description
In the recent pulmonary rehabilitation (PR) statement of the American Thoracic Society/ European Respiratory Society, PR is mentioned to be beneficial by improving exercise capacity, symptoms and quality of life in patients with other chronic respiratory diseases than chronic obstructive pulmonary disease (COPD) (1). Although patients with idiopathic pulmonary fibrosis (IPF) often suffer from psychological distress such as symptoms of anxiety and depression, only little is known about the impact of these mental co-morbidities on PR outcomes.
In a former study the investigators demonstrated that patients with IPF benefit well from an inpatient PR program of only 3 weeks duration by improving exercise capacity (6-Minute walk distance), health-related quality of life as well as symptoms of anxiety and depression. During the 3-months follow-up after PR, most of these improvements disappeared so that this group showed similar values at follow-up compared to baseline. However, in contrast patients from the control-group with usual care worsened significantly during the 6 months study period.
Interestingly, a linear regression analysis revealed that IPF patients with lower levels of anxiety showed the tendency to have the best sustainability in exercise capacity at the 3 months follow-up. Given that maintenance of exercise capacity may be crucial to influence prognosis and the risk of mortality, reducing symptoms of anxiety might be of special interest.
The negative influence of anxiety symptoms on exercise capacity is a new finding in IPF patients but already known in the field of other chronic diseases: in patients with chronic pain and recently also in patients with COPD, "fear avoidance" behavior is discussed as having a direct negative influence on daily physical activity levels. COPD patients seem to develop fear/anxiety of exercise-related dyspnea due to classical and operant conditioning. This may lead to consecutive avoidance of physical activity and other exercises in daily life (2).
Anxiety symptoms and psychological distress have been shown to be related to patients individual illness perceptions and their way of coping with the disease like e.g. problem-focusing coping, looking for information, depressive coping.
In patients with IPF, the role of coping styles in the context of PR has not been investigated yet. It is unclear whether anxiety symptoms are influenced by individual characteristics of IPF patients such as specific coping strategies and illness perceptions and therefore, whether individual coping strategies might have an influence on the PR outcome.
This latter might be an underestimated issue influencing the PR effects in patients with chronic respiratory diseases. Better knowledge in this field is of special clinical importance in order to ensure short- und long term PR success. Potential differences in psychological profiles or coping strategies between COPD and IPF patients might result in disease-specific interventions during and after PR.
Therforme, aim of this study is to evaluate the influence of coping strategies on pulmonary rehabilitation outcomes.
This study is a prospective observational trial. Asssessments will take place at admission of the rehabilitation program, at discharge and partially after 3-month.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Bayern
-
Schoenau Am Königssee, Bayern, Germany, 83471
- Recruiting
- Schoen Klinik BGL
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with idiopathic pulmonary fibrosis with a FVC between 30 to 70% predicted or
- Patients with chronic obstructive pulmonary disease (GOLD stage III and IV)
- Age: 50-80 years
- Medical treatment according to recent guidelines (including long-term oxygen therapy and or non invasive ventilation)
- Written informed consent
Exclusion Criteria:
- General exclusion criteria for physical training like acute coronary syndrome, acute myo- or pericarditis, acute lung embolism, acute heart failure or orthopedic co-morbidities which prevent patients from participating in training program
- Non-compliance
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Coping strategies in anxious vs. non-anxious IPF-patients
Time Frame: Day 1, Day 21 and 3-months after pulmonary rehabilitation program (Day 21)
|
Difference in Essener Coping questionnaire in axious (Hospital anxiety and Depression scale [HADS]>=8points) and non-anxious (HADS<8points) IPF-patients
|
Day 1, Day 21 and 3-months after pulmonary rehabilitation program (Day 21)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between 6-minute walk distance and Essener Coping questionnaire
Time Frame: Day 1 and Day 21
|
The essener Coping questionnaire measures coping mechanisms; a 45-item self-report questionnaire; higher scores indicate higher presence of the respective state
|
Day 1 and Day 21
|
Correlation between Health related Quality of life and Essener Coping questionnaire
Time Frame: Day 1, Day 21 and 3-months after pulmonary rehabilitation program
|
Health related Quality of life will be assessed by chronic respiratory disease questionnaire (CRQ)- a 20-item self-report questionnaire; score 1-7; higher scores indicate a better health-related quality of life ; The essener Coping questionnaire measures coping mechanisms; a 45-item self-report questionnaire; higher scores indicate higher presence of the respective state |
Day 1, Day 21 and 3-months after pulmonary rehabilitation program
|
Correlation between 6-minute walk distance and Hospital Anxiety and Depresion scale
Time Frame: Day 1 and Day 21
|
Anxiety/Depression measured by Hospital Anxiety and Depression Scale (HADS) - a screening questionnaire including 6 questions about depression and 8 questions about anxiety; higher scores indicate higher presence of anxiety/ depression
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and COPD anxiety questionnaire
Time Frame: Day 1 and Day 21
|
assessed by the German "COPD Angst Fragebogen" (CAF) - a 20-item self-report questionnaire, rated on a Lickert-scale (score 0-4); maximum score: 80 points; higher scores indicate higher anxiety levels.
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and Illness Perception Questionnaire
Time Frame: Day 1 and Day 21
|
assessed by the Illness perception Questionnaire, revised (IPQ-R) - 18 items, score 1-5; higher scores indicate a worse illness perception, except of item 7,9,10,11,12.
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and Patient-Health questionnaire
Time Frame: Day 1 and Day 21
|
Depression measured by Patient-Health questionnaire including 9 items; each question range from 0 to 3; higher scores indicate higher presence of the respective state
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and Health related Quality of life
Time Frame: Day 1 and Day 21
|
Health related Quality of life will be assessed by chronic respiratory disease questionnaire (CRQ)- a 20-item self-report questionnaire; score 1-7; higher scores indicate a better health-related quality of life
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and SF-36 survey
Time Frame: Day 1 and Day 21
|
Health related quality of life will be measured by SF-36 questionnaire; a screening questionnaire including 36-items; higher score indicate higher quality of life
|
Day 1 and Day 21
|
Correlation between 6-minute walk distance and King´s Brief Interstitial lung disease questionnaire
Time Frame: Day 1 and Day 21
|
Health Status measured by King's Brief Interstitial lung disease questionnaire including 15 items; higher scores indicate better respective state
|
Day 1 and Day 21
|
Correlation between physical activity level and Essener Coping questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
The essener Coping questionnaire measures coping mechanisms; a 45-item self-report questionnaire; higher scores indicate higher presence of the respective state
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and Hospital Anxiety and Depresion scale
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Anxiety/Depression measured by Hospital Anxiety and Depression Scale (HADS) - a screening questionnaire including 6 questions about depression and 8 questions about anxiety; higher scores indicate higher presence of anxiety/ depression
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and COPD anxiety questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
assessed by the German "COPD Angst Fragebogen" (CAF) - a 20-item self-report questionnaire, rated on a Lickert-scale (score 0-4); maximum score: 80 points; higher scores indicate higher anxiety levels.
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and Illness Perception Questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
assessed by the Illness perception Questionnaire, revised (IPQ-R) - 18 items, score 1-5; higher scores indicate a worse illness perception, except of item 7,9,10,11,12.
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and Patient-Health questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Depression measured by Patient-Health questionnaire including 9 items; each question range from 0 to 3; higher scores indicate higher presence of the respective state
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and chronic respiratory disease questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Depression measured by Patient-Health questionnaire including 9 Items; each question range from 0 to 3; higher scores indicate higher presence of the respective state
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity level and SF-36 survey
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Health related quality of life will be measured by SF-36 questionnaire; a screening questionnaire including 36-items; higher score indicate higher quality of life
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Correlation between physical activity Level and King´s Brief Interstitial lung disease questionnaire
Time Frame: 2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Health Status measured by King's Brief Interstitial lung disease questionnaire including 15 items; higher scores indicate better respective state
|
2 weeks and 3 months after pulmonary rehabilitation program completion (Day 21) activity monitoring for 5 week days each
|
Differences in Coping mechanisms between IPF and COPD patients
Time Frame: Day 1, Day 21 and 3-months after pulmonary rehabilitation program (Day 21)
|
The essener Coping questionnaire measures coping mechanisms; a 45-item self-report questionnaire; higher scores indicate higher presence of the respective state
|
Day 1, Day 21 and 3-months after pulmonary rehabilitation program (Day 21)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum In: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.
- Hallas CN, Howard C, Theadom A, Wray J. Negative beliefs about breathlessness increases panic for patients with chronic respiratory disease. Psychol Health Med. 2012;17(4):467-77. doi: 10.1080/13548506.2011.626434. Epub 2012 Feb 13.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PsyLu-Study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States